Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)

China · Delayed Price · Currency is CNY

24.20

-0.54 (-2.18%)

At close: May 12, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals			1.75B	1.81B	2.09B	2.00B	1.68B
Pharmaceuticals Growth			-3.58%	-13.08%	4.63%	19.00%	20.59%
Total			1.75B	1.81B	2.09B	2.00B	1.68B
Total Growth			-3.58%	-13.08%	4.63%	19.00%	20.59%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China			-	-	-	-	1.49B
China Growth			-	-	-	-	22.43%
Overseas			-	-	-	-	185.45M
Total			-	-	-	-	1.68B
Total Growth			-	-	-	-	20.59%

Source: S&P Global Market Intelligence.